2011•Practical Journal of Cardiac Cerebral Pneumal and Vascular DiseaseRequires access

Effects of Edaravone Combined with Simvastatin in Patients with Acute Cerebral Infarction with High Sensitivity C-reactive Protein and Blood Lipids

Yin Cao

Open publisher page 0 citations

Abstract

Objective To observe the effects of Edaravone combined with simvastatin in patients with acute cerebral infarction with high sensitivity C-reactive protein and blood lipids.Methods 135 patients with acute cerebral infarction were randomly divided into the Conventional group and the edaravone combined with simvastatin group.The basis of conventional treatment group were simvastatin 20mg plus oral,he edaravone combined with simvastatin group plus saline intravenous 100ml infusion of edaravone 30mg,2 times/day,the rest of the treatment with the conventional group.Two groups were compared hs-CRP and lipid and NIHSS score.Results Two groups of serum concentrations of hs-CRP were significantly decreased(P0.05),However,edaravone combined with simvastatin groups decreased more significantly(P0.05).The NIHSS of combination group decreased significantly(P0.05).The decrease in lipid levels between the two groups was not significant(P0.05).Conclusion Combined with simvastatin edaravone treatment of acute cerebral infarction,without affecting the lipid-lowering effects of simvastatin at the same time,can also reduce hs-CRP levels,reduce the damage to the nervous system.

About this research paper

What this paper is about

Objective To observe the effects of Edaravone combined with simvastatin in patients with acute cerebral infarction with high sensitivity C-reactive protein and blood lipids.Methods 135 patients with acute cerebral infarction were randomly divided into the Conventional group and the edaravone combined with simvastatin group.The basis of conventional treatment group were simvastatin 20mg plus oral,he edaravone combined with simvastatin group plus saline intravenous 100ml infusion of edaravone 30mg,2 times/day,the rest of the treatment with the conventional group.Two groups were compared hs-CRP and lipid and NIHSS score.Results Two groups of serum concentrations of hs-CRP were significantly decreased(P0.05),However,edaravone combined with simvastatin groups decreased more significantly(P0.05).The NIHSS of combination group decreased significantly(P0.05).The decrease in lipid levels between the two groups was not significant(P0.05).Conclusion Combined with simvastatin edaravone treatment of acute cerebral infarction,without affecting the lipid-lowering effects of simvastatin at the same time,can also reduce hs-CRP levels,reduce the damage to the nervous system.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effects of Edaravone combined with simvastatin in patients with acute cerebral infarction with high sensitivity C-reactive protein and blood lipids.Methods 135 patients with acute cerebral infarction were randomly divided into the Conventional group and the edaravone combined with simvastatin group.The basis of conventional treatment group were simvastatin 20mg plus oral,he edaravone combined with simvastatin group plus saline intravenous 100ml infusion of edaravone 30mg,2 times/day,the rest of the treatment with the conventional group.Two groups were compared hs-CRP and lipid and NIHSS score.Results Two groups of serum concentrations of hs-CRP were significantly decreased(P0.05),However,edaravone combined with simvastatin groups decreased more significantly(P0.05).The NIHSS of combination group decreased significantly(P0.05).The decrease in lipid levels between the two groups was not significant(P0.05).Conclusion Combined with simvastatin edaravone treatment of acute cerebral infarction,without affecting the lipid-lowering effects of simvastatin at the same time,can also reduce hs-CRP levels,reduce the damage to the nervous system.

Key concepts: Edaravone, Simvastatin, Medicine, Anesthesia, Blood lipids, Cerebral infarction, Internal medicine, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Edaravone Combined with Simvastatin in Patients with Acute Cerebral Infarction with High Sensitivity C-reactive Protein and Blood Lipids — Research Paper | ScholarLens